Description
CHEMO MEDICATION: CABOZANTINIB (COMETRIQ) 140MG
First action · last action
2013-12-19 · 2014-03-24
Transactions
2
First transaction's obligation
$14,821
Base + all options value (sum of deltas)
$7,411
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D3010E
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2013-12-19+$14,821= $14,821
- Mod P000012014-03-24-$7,411= $7,411
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2013-12-19 | +$14,821 | $14,821 | CHEMO MEDICATION: CABOZANTINIB (COMETRIQ) 140MG |
| Mod P00001· FUNDING ONLY ACTION | 2014-03-24 | −$7,411 | $7,411 | CHEMO MEDICATION: CABOZANTINIB (COMETRIQ) 140MG |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI R47FPKTS9T63)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36F79722D0147 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2022 |
| VA26117F0396 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $76,355 | FY2017 |
| VA26117F0347 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $6,925 | FY2017 |
| VA26117F0102 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $6,925 | FY2017 |
| VA25817J0101 | 258-NETWORK CNTRCT OFF 22G (36C258) · 6505 · DRUGS AND BIOLOGICALS | $6,875 | FY2017 |
| VA26317J0003 | 618-MINNEAPOLIS VA MED CTR (00618) · 6505 · DRUGS AND BIOLOGICALS | $13,750 | FY2017 |
Other recipients under 6515 from 583-INDIANAPOLIS (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25116P1468 | EDWARDS LIFESCIENCES LLC | 583-INDIANAPOLIS | $13,078 | FY2016 |
| VA25116J1123 | REHABILITATION INSTITUTE OF INDIANAPOLIS, INC. | 583-INDIANAPOLIS | $7,317 | FY2016 |
| VA25116J1124 | EDWARDS LIFESCIENCES LLC | 583-INDIANAPOLIS | $13,078 | FY2016 |
| VA25116F1112 | TRYCO INCORPORATED | 583-INDIANAPOLIS | $5,883 | FY2016 |
| VA25116F1113 | BRUNO INDEPENDENT LIVING AIDS INC | 583-INDIANAPOLIS | $7,204 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25114F0627_3600_V797D3010E_3600 · retrieved 2026-09-26.